Accurate lists of current clinical trials are maintained by a number of national authorities. The information is intended for people looking for trials to participate in. However, it may also be useful for those interested in the research that is currently underway.
The databases listed below provide information on current clinical trials (Project title, Description of project, Location, Start date, End date). It is worth searching more than one of these databases as none appear comprehensive:
We have an ongoing list of updates to trials and new trials here:
-
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis18 September 2007
Condition: Aspergillosis
Interventions: Drug: voriconazole; Drug: anidulafungin
Sponsor: Pfizer
Completed -
Prophylaxis of Fungal Invasive Infections in Leukemia13 July 2007
Condition: Invasive Pulmonary Aspergillosis
Intervention: Drug: Caspofungin
Sponsor: Northern Italy Leukemia Group
Completed -
Surveillance of Fungal Infections During Construction Activity15 May 2007
Condition: Aspergillosis
Intervention:
Sponsor: University Hospital Inselspital, Berne
Completed -
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease19 April 2007
Conditions: Graft Versus Host Disease; Infection; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Genetic: polymerase chain reaction; Other: bronchoalveolar lavage; Other: immunoenzyme technique; Other: laboratory biomarker analysis; Procedure: bronchoscopy; Procedure: management of therapy complications
Sponsor: St. Bartholomew’s Hospital
Unknown status -
A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis18 January 2007
Conditions: Aspergillosis/Blood; Aspergillosis/Invasive
Interventions: Drug: micafungin; Drug: voriconazole
Sponsor: Astellas Pharma Inc
Withdrawn -
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis19 December 2006
Conditions: Aspergillosis; Invasive Fungal Infection
Interventions: Drug: Isavuconazole; Drug: Voriconazole
Sponsors: Astellas Pharma Inc; Basilea Pharmaceutica International Ltd
Completed -
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis27 November 2006
Condition: Invasive Aspergillosis
Intervention: Drug: caspofungin
Sponsor: University of Cologne
Completed -
Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis23 October 2006
Conditions: Acute Myeloid Leukemia; Allogeneic Haematopoietic Progenitor Cell Transplant
Intervention: Drug: liposomal Amphotericine B
Sponsor: PETHEMA Foundation
Completed -
Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection16 October 2006
Conditions: Candidiasis; Aspergillosis
Intervention: Drug: Caspofungin
Sponsors: PETHEMA Foundation; GTEI; SEMICYUC
Completed -
Micafungin Salvage Mono-therapy in Invasive Aspergillosis14 September 2006
Condition: Invasive Aspergillosis
Interventions: Drug: Micafungin; Drug: Systemic antifungal therapy
Sponsor: Astellas Pharma Inc
Terminated